WSK-V102

· WestVac Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WSK-V102, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102) [Phase 1]